6 Patents
- US125288272026Tricyclic Heteroaryl-substituted Quinoline and Azaquinoline Compounds as PAR4 Inhibitors
Bristol-myers Squibb Company
0 cites - US120844522024Imidazothiadiazole and Imidazopyrazine Derivatives as Protease Activated Receptor 4 (PAR4) Inhibitors for Treating Platelet Aggregation
Université De Montréal
0 cites - 0 cites
- 0 cites
- US119326582024Tricyclic Heteroaryl-substituted Quinoline and Azaquinoline Compounds as PAR4 Inhibitors
Bristol-myers Squibb Company
0 cites - 0 cites